Skandinaviska Enskilda Banken (SEB)
INZY

Skandinaviska Enskilda Banken (SEB)’s Inozyme Pharma INZY Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-377,227
Closed -$1.51M – 842
2025
Q2 		$1.51M Buy
+377,227
New +$934K 0.01% 614

Skandinaviska Enskilda Banken (SEB)'s INZY Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 377,227 shares — an estimated $1.51M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $1.51M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 377,227 Inozyme Pharma shares in Q3 2025, an estimated $1.51M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Inozyme Pharma position peaked at $1.51M in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.